AssayGate
AssayGate, Inc. is dedicated to providing comprehensive, high-quality, and cost-effective biomarker testing services and custom assay development for life sciences, biomedical, drug discovery, and pharmaceutical research communities. They utilize multiple assay platforms including ELISA, multiplex bead-based assays, MSD-ECL, Simoa, and Olink, and offer testing for over 3,800 protein markers across various species. Their mission is to accelerate scientific discoveries by delivering reliable and affordable testing services with broad sample and assay platform options.
Industries
Nr. of Employees
small (1-50)
AssayGate
Ijamsville, Maryland, United States, North America
Products
Conventional sandwich ELISA kits (96 tests) for protein biomarkers
Pre-formulated sandwich ELISA kits supplied as 96-test plates with standards, detection antibodies, streptavidin-HRP, diluents, wash buffer, chromogen and stop solution for colorimetric quantification of protein biomarkers in serum, plasma, culture supernatants and other matrices.
Conventional sandwich ELISA kits (96 tests) for protein biomarkers
Pre-formulated sandwich ELISA kits supplied as 96-test plates with standards, detection antibodies, streptavidin-HRP, diluents, wash buffer, chromogen and stop solution for colorimetric quantification of protein biomarkers in serum, plasma, culture supernatants and other matrices.
Services
Laboratory-based testing of protein biomarkers using multiple platforms (sandwich ELISA, bead-based multiplex, electrochemiluminescence multiplex, single-molecule ultra-sensitive and high-throughput proteomics). Includes QC, sample handling and data reporting.
Custom development of immunoassays tailored to client requirements across multiple platforms to achieve desired sensitivity and specificity, with project management from design to delivery.
Manufacture of custom immunoassay kits including pre-coated plates and all kit reagents, packaged and stored under cold-chain conditions.
Multiplex panel testing using bead-based suspension arrays for varied biomarker panels (e.g., angiogenesis, cytokines, cardiovascular, metabolic and neuro panels).
High-sensitivity multiplex testing using electrochemiluminescence detection for low-abundance biomarkers and panels requiring high precision.
Ultra-sensitive biomarker detection services using single-molecule immunoassay approaches to measure targets not detectable with conventional methods.
Laboratory-based testing of protein biomarkers using multiple platforms (sandwich ELISA, bead-based multiplex, electrochemiluminescence multiplex, single-molecule ultra-sensitive and high-throughput proteomics). Includes QC, sample handling and data reporting.
Custom development of immunoassays tailored to client requirements across multiple platforms to achieve desired sensitivity and specificity, with project management from design to delivery.
Manufacture of custom immunoassay kits including pre-coated plates and all kit reagents, packaged and stored under cold-chain conditions.
Multiplex panel testing using bead-based suspension arrays for varied biomarker panels (e.g., angiogenesis, cytokines, cardiovascular, metabolic and neuro panels).
High-sensitivity multiplex testing using electrochemiluminescence detection for low-abundance biomarkers and panels requiring high precision.
Ultra-sensitive biomarker detection services using single-molecule immunoassay approaches to measure targets not detectable with conventional methods.
Expertise Areas
- Immunoassay development and validation
- Multiplex protein biomarker testing
- Ultra-sensitive biomarker detection
- Custom assay development and kit manufacture
Key Technologies
- Sandwich ELISA (microplate-based)
- Bead-based suspension multiplex immunoassays (Luminex)
- Electrochemiluminescence multiplex immunoassays (MSD-ECL)
- Single-molecule array immunoassay (ultra-sensitive)
News & Updates
AssayGate partners with Quanterix to develop ultra-sensitive Simoa assay kits and with Meso Scale Discovery for high-sensitivity multiplex assays on MSD-ECL platform.
AssayGate partners with Quanterix to develop ultra-sensitive Simoa assay kits and with Meso Scale Discovery for high-sensitivity multiplex assays on MSD-ECL platform.